/Investor DB

Canaan Partners — 2017 Investments

13 investments dated 2017 · listed companies and verified rows first · show all

Cardlyticscardlytics.comin𝕏NASDAQ: CDLXMay 2017

Cardlytics operates a commerce media platform that uses card-linked purchase data to deliver targeted offers and closed-loop measurement for marketers and advertisers, and personalized rewards programs for banks and publishers.

AdTechFintechMarketing TechAtlanta, US

Scott Grimes(Founder)inLynne Laube(Founder)inKirk Somers(Executive Officer)inDavid Evans(Executive Officer)inAmit Gupta(Chief Executive Officer and Director)in

BoardJohn Klinck(Director)in

Board seatJohn Balen· per SEC Form D

Co-investorsBaroda VenturesKinetic Ventures, L.L.C.Next Coast VenturesSavano Capital PartnersDiscovery CapitalHyperplane Venture Capital+2 more

Aevaaeva.comin𝕏NASDAQ: AEVASeries A · Jan 2017 · $45M

Aeva develops FMCW-based 4D LiDAR sensors and perception software that measure velocity and range simultaneously, using silicon photonics to put LiDAR elements on a chip.

HardwareMobility & TransportationSemiconductorsPalo Alto, US

SOROUSH SALEHIAN DARDASHTI(Executive Officer, Director)MINA REZK(Executive Officer, Director)inSoroush Salehian(Founder)inMina Rezk(Founder)

BoardSHAHIN FARSHCHI(Director)inYuan Chen(Capital Allocator)in

Co-investors11.2 CapitalLux CapitalNext47Socii CapitalLockheed Martin VenturesPorsche Ventures

Arrakis Therapeuticsarrakistx.comin𝕏Series A · Feb 2017 · $38M✓ verified

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Michael Gilman(Executive Officer, Director)inMark DeLong(CEO)inDavid Neafus(Executive Officer)inRussell C. Petter(Executive Officer)

BoardAlan E. Walts(Director)in

Board seatColleen Cuffaro· per SEC Form D

Co-investorsPfizer VenturesAdvent Life SciencesHBM Healthcare InvestmentsHBM PartnersNextech InvestOUP (Osage University Partners)+2 more

Even Financialevenfinancial.cominFeb 2017 · $18.8MAcquired

Even Financial, operating as Engine, runs a financial services marketplace and matching network that connects consumers with financial products through APIs and white-labeled experiences.

AI & Machine LearningFintechMarketplacesBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

Board seatBrendan Dickinson· per SEC Form D

Co-investorsAAF Management Ltd.Conversion CapitalF-Prime CapitalGreatPoint VenturesMassMutual VenturesValuestream Ventures+6 more

Hyalex Orthopaedicshyalex.comin𝕏Series A · May 2017 · $16M

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Chief Executive Officer and President)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)

BoardMichael Hawkins(Director)William Harrington(Director)in

Board seatWende Hutton· per SEC Form D

Co-investorsOUP (Osage University Partners)Treo Ventures, LlcJohnson & Johnson Innovation – JJDC

Onkos Surgicalonkossurgical.comin𝕏Series B · Apr 2017 · $23M

Onkos Surgical develops limb salvage and orthopedic reconstruction implants and systems for treating musculoskeletal cancer and complex orthopedic conditions.

HardwareHealthtechMedical DevicesParsippany, US

Patrick Treacy(Founder)inAntony Koblish(Director, Promoter)inBrad Tyler(Executive Officer)in

BoardAdele Oliva(Director)inPaul Touhey(Director)

Board seatStephen Bloch· per SEC Form D

Co-investors1315 CapitalJSD Capital, LLCRocky Point VenturesSV Health Investors

Spyryx BiosciencesinJun 2017

BiotechResearch Triangle Park, US

Andrew Jordan(Executive Officer, Director)John Taylor(Executive Officer, Director, Promoter)Robert Tarran(Director)

BoardDonald Rose(Director)

Board seatTimothy Shannon· per SEC Form D

Co-investors5AM VenturesHatteras Venture Partners

Truveristruveris.comin𝕏Series C · Aug 2017 · $15M

Truveris offers a technology platform with claims analytics and PBM (pharmacy benefit manager) oversight to reduce pharmacy benefit costs through contract optimization for employers.

Data & InfrastructureDigital HealthHealthtechSaaSNew York, US

Anthony Joseph Loiacono(Executive Vice-President, Sales and Marketing)Michael Facendola(Executive Officer)inLouise Shea(Chief Pharmacy Officer)inBryan Birch(Chief Executive Officer)in

BoardPhilippe Chambon(Director)Stephen M. Bloch(Director)in

Board seatStephen Bloch· per SEC Form D

Co-investorsMcKesson VenturesTribeca Venture PartnersNew Leaf Venture Partners

Ascendifyascendify.comin𝕏Series A · May 2017 · $11M

Radancy offers an AI-powered CRM platform for recruiting teams that consolidates candidate data from multiple sources, automates matching and outreach, and provides analytics to optimize hiring workflows.

AI & Machine LearningHR TechSaaSSan Francisco, US

Lauren Smith(Executive Officer, Director)inMatt Hendrickson(Executive Officer, Director)in

BoardTom Spengler(Director)Richard Natsch(Director)

Co-investorsBlossom Street VenturesCisco InvestmentsGE Ventures

Countablecountable.comMar 2017 · $2M

Actionable is a self-service advocacy platform that lets organizations launch, manage, and measure campaigns such as petitions, pledges, lawmaker messages, and supporter mobilization without developers or consultants.

GovTechImpact & Social GoodSaaSOakland, US

Bart Myers(Executive Officer, Director)

BoardJoydeep Bhattacharyya(Director)in

Co-investorsFernbrook Capital ManagementSilicon ValleySource VenturesF-Prime Capital

Nodenode.ioJul 2017acquired by SugarCRM

Data intelligence layer providing personalized B2B recommendations.

Data & InfrastructureSan Francisco, US

Falon Fatemi(Executive Officer, Director)in

Co-investors500 GlobalBase Venture Management, Inc.Dreamers VCGFR FundJetBlue VenturesMS&AD Ventures+14 more

Ollieollie.comAug 2017 · $12.6M

Ollie makes nutrient-rich, perfectly-portioned dog food recipes developed by chefs and food scientists, along with health monitoring for dogs.

ConsumerDirect to ConsumerFoodTech

Nick Staffordin

Co-investorsPrimary Venture PartnersCorrelation VenturesLerer HippeauPrimary VenturesRosecliff Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Dauntless Pharmaceuticals

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.